Home » Psychology news » Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor

Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor

November 6, 2015 by

Investigators report the first successful use of a targeted therapy to treat a patient with BRAF-mutant craniopharyngioma, a debilitating, recurrent brain tumor.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>